Dedicated to extending and improving the lives of cancer patients by designing and developing next generation #immunotherapy treatments

Consulting

iTeos Therapeutics

iTeos Therapeutics' headquarters in Charleroi, Belgium

The Cambridge office likely focuses on regulatory operations, strategic product management, and corporate leadership.

Cambridge

Nic M

Sandrine Segura Gozzini

David Feltquate

Benoit Dethy

Matt Call

Philippe Brantegem

Paul Sockol

Laurent Kerstens

Tim Debotze

Maud Clouseau

Michele Kelly

Madhu Mawal-Dewan

Gregory Driessens

Prakash Bolleddula

Steven Thys

Olivier de Henau

Clarisse Truong-Maurin

Erica Houthuys

Phil Beard

Aaron Davis

Tony Ho

Gordon Freeman

Derek Dirocco

Tim Van Hauwermeiren

Florent Ginhoux

Matthew Vander Heiden

Roberta Zappasodi

Benoit Van den Eynde

David Hallal

Ann Rhoads

Robert Iannone

The Scientific Research Team at iTeos Therapeutics conducts cutting-edge research to advance the development of innovative immunotherapy treatments for cancer patients. Comprised of experienced scientists and advisors, the team focuses on pre-clinical studies, biomarker identification, and translational medicine to optimize therapeutic strategies and enhance patient outcomes. Through collaboration and rigorous scientific inquiry, the team strives to identify novel cancer targets and validate new treatment approaches.

Scientific Research Team

The Clinical Operations Team at iTeos Therapeutics is responsible for the planning, execution, and management of clinical trials aimed at advancing immunotherapy treatments for cancer patients. This diverse team collaborates on trial design, data management, regulatory compliance, and operational strategies, ensuring that research initiatives are conducted efficiently and ethically to deliver valuable insights and outcomes.

Clinical Operations Team

This department oversees strategic direction and decision-making for the organization.

Executive Management

The Leadership Team at iTeos Therapeutics is responsible for setting the strategic direction of the company, overseeing operations, and ensuring financial health while fostering a culture of innovation. Comprised of key executives, including the COO, CFO, and Chief Scientific Officers, they collaborate to drive the development of next-generation immunotherapy treatments, align organizational goals, and optimize resource allocation to extend and improve the lives of cancer patients.

Leadership Team

This department oversees the planning and execution of clinical trials and assessments to ensure the quality and effectiveness of medical treatments.

Clinical Development

This department focuses on conducting and supporting research initiatives to drive knowledge and innovation.

Research Division

iTeos Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Operations Team

Executive Management

Leadership Team

Clinical Development

Research Division

Offices

iTeos Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Clinical Operations Team

Executive Management

Leadership Team

Clinical Development

Research Division

Offices

Related companies